Elixinol Historical Cash Flow

EXL Stock

0.05 0.01 31.43%

Analysis of Elixinol Wellness cash flow over time is an excellent tool to project Elixinol Wellness future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Dividends Paid of 1.4 M or Capital Expenditures of 16.1 K as it is a great indicator of Elixinol Wellness ability to facilitate future growth, repay debt on time or pay out dividends.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Elixinol Wellness latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Elixinol Wellness is a good buy for the upcoming year.

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Elixinol Wellness Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Elixinol Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Elixinol balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Elixinol's non-liquid assets can be easily converted into cash.

Elixinol Wellness Cash Flow Chart

At this time, Elixinol Wellness' Change To Inventory is comparatively stable compared to the past year. Change To Account Receivables is likely to gain to about 1.4 M in 2024, despite the fact that Net Borrowings is likely to grow to (647.2 K).

Dividends Paid Capital Expenditures End Period Cash Flow Begin Period Cash Flow

Dividends Paid

The total amount of dividends that a company has paid out to its shareholders over a specific period.

Capital Expenditures

Capital Expenditures are funds used by Elixinol Wellness to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Elixinol Wellness operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Most accounts from Elixinol Wellness' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Elixinol Wellness current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Elixinol Wellness Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2021	2023	2024 (projected)
Dividends Paid	1.3M	1.5M	1.4M
Depreciation	1.5M	597K	567.2K

Dividends Paid Depreciation

Elixinol Wellness cash flow statement Correlations

	Change To Inventory	Investments	Change In Cash	Net Borrowings	Depreciation	Dividends Paid	Capital Expenditures	Change To Account Receivables	Change To Operating Activities	Net Income	Change To Netincome	Change To Liabilities	Sale Purchase Of Stock	Stock Based Compensation	Free Cash Flow	Change In Working Capital	Other Non Cash Items	End Period Cash Flow	Begin Period Cash Flow	Issuance Of Capital Stock
Change To Inventory		0.59	0.57	-0.46	0.18	-0.38	-0.55	-0.34	-0.32	0.66	-0.63	0.61	0.45	0.44	0.88	0.91	-0.61	-0.19	-0.66	-0.25
Investments	0.59		-0.07	-0.34	0.38	-0.71	-0.36	-0.14	-0.14	-0.13	0.05	0.62	-0.32	-0.44	0.26	0.56	0.13	-0.23	-0.46	-0.6
Change In Cash	0.57	-0.07		-0.22	-0.01	0.5	-0.25	-0.33	-0.25	0.52	-0.37	0.53	0.74	0.75	0.68	0.52	-0.44	0.5	-0.25	0.57
Net Borrowings	-0.46	-0.34	-0.22		-0.92	0.27	-0.46	0.24	0.96	-0.27	0.1	-0.12	-0.17	-0.11	-0.08	-0.06	0.04	-0.02	-0.01	-0.1
Depreciation	0.18	0.38	-0.01	-0.92		-0.26	0.63	-0.16	-0.89	-0.11	0.26	0.07	-0.11	-0.23	-0.26	-0.2	0.32	0.12	0.23	0.11
Dividends Paid	-0.38	-0.71	0.5	0.27	-0.26		0.19	-0.01	0.13	-0.11	0.25	-0.17	0.51	0.39	-0.14	-0.34	0.15	0.69	0.52	0.93
Capital Expenditures	-0.55	-0.36	-0.25	-0.46	0.63	0.19		-0.01	-0.61	-0.27	0.4	-0.4	-0.27	-0.21	-0.73	-0.82	0.42	0.32	0.63	0.4
Change To Account Receivables	-0.34	-0.14	-0.33	0.24	-0.16	-0.01	-0.01		0.3	-0.4	0.41	-0.53	-0.09	-0.16	-0.26	-0.2	0.36	-0.52	-0.18	-0.07
Change To Operating Activities	-0.32	-0.14	-0.25	0.96	-0.89	0.13	-0.61	0.3		-0.31	0.12	-0.08	-0.15	-0.18	0.0	0.09	0.07	-0.16	-0.11	-0.23
Net Income	0.66	-0.13	0.52	-0.27	-0.11	-0.11	-0.27	-0.4	-0.31		-0.96	0.17	0.57	0.83	0.78	0.56	-0.97	-0.18	-0.46	-0.06
Change To Netincome	-0.63	0.05	-0.37	0.1	0.26	0.25	0.4	0.41	0.12	-0.96		-0.22	-0.4	-0.71	-0.79	-0.62	0.99	0.28	0.55	0.28
Change To Liabilities	0.61	0.62	0.53	-0.12	0.07	-0.17	-0.4	-0.53	-0.08	0.17	-0.22		-0.06	0.03	0.53	0.67	-0.19	0.4	-0.48	-0.14
Sale Purchase Of Stock	0.45	-0.32	0.74	-0.17	-0.11	0.51	-0.27	-0.09	-0.15	0.57	-0.4	-0.06		0.83	0.58	0.36	-0.47	0.11	-0.02	0.56
Stock Based Compensation	0.44	-0.44	0.75	-0.11	-0.23	0.39	-0.21	-0.16	-0.18	0.83	-0.71	0.03	0.83		0.69	0.4	-0.78	0.08	-0.28	0.4
Free Cash Flow	0.88	0.26	0.68	-0.08	-0.26	-0.14	-0.73	-0.26	0.0	0.78	-0.79	0.53	0.58	0.69		0.94	-0.81	-0.17	-0.73	-0.16
Change In Working Capital	0.91	0.56	0.52	-0.06	-0.2	-0.34	-0.82	-0.2	0.09	0.56	-0.62	0.67	0.36	0.4	0.94		-0.61	-0.24	-0.81	-0.37
Other Non Cash Items	-0.61	0.13	-0.44	0.04	0.32	0.15	0.42	0.36	0.07	-0.97	0.99	-0.19	-0.47	-0.78	-0.81	-0.61		0.25	0.55	0.19
End Period Cash Flow	-0.19	-0.23	0.5	-0.02	0.12	0.69	0.32	-0.52	-0.16	-0.18	0.28	0.4	0.11	0.08	-0.17	-0.24	0.25		0.48	0.73
Begin Period Cash Flow	-0.66	-0.46	-0.25	-0.01	0.23	0.52	0.63	-0.18	-0.11	-0.46	0.55	-0.48	-0.02	-0.28	-0.73	-0.81	0.55	0.48		0.56
Issuance Of Capital Stock	-0.25	-0.6	0.57	-0.1	0.11	0.93	0.4	-0.07	-0.23	-0.06	0.28	-0.14	0.56	0.4	-0.16	-0.37	0.19	0.73	0.56

Click cells to compare fundamentals

Elixinol Wellness Account Relationship Matchups

Elixinol Wellness cash flow statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Change To Inventory	(25.4M)	(2.2M)	(244K)	227K	470K	493.5K
Investments	(7.2M)	2.6M	(10K)	(869K)	(1.0M)	(1.1M)
Change In Cash	(22.7M)	7.5M	(15.1M)	(9.8M)	(2.2M)	(2.0M)
Net Borrowings	(729K)	(1.4M)	(1.0M)	(757K)	(681.3K)	(647.2K)
Total Cashflows From Investing Activities	(17.9M)	2.6M	172K	(869K)	(999.4K)	(1.0M)
Other Cashflows From Financing Activities	(729K)	(1.4M)	(1.0)	(757K)	(738K)	(701.1K)
Depreciation	2.8M	3.2M	1.5M	721K	597K	567.2K
Capital Expenditures	11.1M	328K	292K	12K	17K	16.2K
Total Cash From Operating Activities	(51.1M)	(22.6M)	(14.1M)	(8.2M)	(2.8M)	(2.6M)
Change To Account Receivables	1.5M	709K	(2.0M)	144K	1.4M	1.4M
Change To Operating Activities	(2.7M)	1.2M	349K	230K	264.5K	277.7K
Net Income	(80.4M)	(104.5M)	(17.0M)	(10.6M)	(7.5M)	(7.1M)
Total Cash From Financing Activities	46.4M	27.5M	(1.2M)	(757K)	1.6M	1.5M
Other Cashflows From Investing Activities	(6.8M)	2.8M	332K	(1.1M)	(1.2M)	(1.2M)
Change To Netincome	64.6M	75.5M	4.0M	1.5M	1.7M	1.7M
Change To Liabilities	(8.9M)	3.8M	(614K)	(903K)	(812.7K)	(772.1K)
Sale Purchase Of Stock	(2.8M)	(2.5M)	(110K)	(199K)	(179.1K)	(170.1K)
Stock Based Compensation	130.0K	(293K)	194K	241K	675K	708.8K
Free Cash Flow	(62.2M)	(22.9M)	(14.4M)	(8.2M)	(2.8M)	(2.9M)
Change In Working Capital	(28.7M)	(1.2M)	(2.6M)	180K	2.0M	2.1M
Other Non Cash Items	62.7M	75.8M	9.9M	3.4M	1.5M	1.4M
End Period Cash Flow	20.2M	27.7M	12.6M	2.9M	708K	672.6K
Begin Period Cash Flow	42.9M	20.2M	27.7M	12.6M	2.9M	2.7M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Elixinol Stock Analysis

When running Elixinol Wellness' price analysis, check to measure Elixinol Wellness' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elixinol Wellness is operating at the current time. Most of Elixinol Wellness' value examination focuses on studying past and present price action to predict the probability of Elixinol Wellness' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elixinol Wellness' price. Additionally, you may evaluate how the addition of Elixinol Wellness to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC